BCL2 and ovarian carcinoma: The RBP ribonucleoprotein 1, translational regulator 1 (LARP1) promotes ovarian cancer progression and by altering the stability of its target mRNAs B cell lymphoma 2 (BCL2) and BCL-2–interacting killer (BIK) (Hopkins et al., 2016).